• Thu, December 29, 2022
  • Thu, December 22, 2022
  • Fri, December 23, 2022
  • Wed, December 28, 2022
  • Tue, December 27, 2022

David Risinger Maintained (AMGN) at Hold with Increased Target to $282 on, Dec 22nd, 2022

David Risinger of SVB Leerink, Maintained "Amgen Inc." (AMGN) at Hold with Increased Target from $256 to $282 on, Dec 22nd, 2022.

David has made no other calls on AMGN in the last 4 months.



There are 6 other peers that have a rating on AMGN. Out of the 6 peers that are also analyzing AMGN, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gregory Renza of "RBC Capital" Maintained at Hold with Increased Target to $240 on, Friday, November 4th, 2022


These are the ratings of the 5 analyists that currently disagree with David


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $299 on, Tuesday, December 13th, 2022
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $310 on, Tuesday, December 6th, 2022
  • Trung Huynh of "Credit Suisse" Initiated at Sell and Held Target at $240 on, Friday, November 18th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $282 on, Friday, November 4th, 2022
  • Carter Gould of "Barclays" Downgraded from Hold to Sell and Held Target at $234 on, Monday, October 31st, 2022

Like: 👍